Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Photo/Multimedia, Survey

New CareQuest Institute Analysis: More Than 14 Million People May Lose Dental Coverage Under Medicaid Redetermination


A new analysis from CareQuest Institute for Oral Health® ? a leading national nonprofit focused on creating a more accessible, equitable, and integrated oral health system ? reveals that more than 14 million people across the country may lose dental coverage under the Medicaid redetermination process that began on April 1.

As the expiration of the national COVID-19 Public Health Emergency (PHE) on May 11 approaches, states are required to begin conducting eligibility redeterminations and un-enrolling individuals determined to no longer be eligible for their state's Medicaid program.

Approximately 15 million people are expected to lose their health coverage as a result. But until now, little to no data has been reported about how many people are expected to lose dental coverage as well. The new analysis released by CareQuest Institute shows that 28% of the country's adult population currently enrolled in Medicaid may lose dental coverage.

As people are removed from Medicaid coverage and seek to secure coverage through other programs or the private market, there is no guarantee that they will find or be able to afford coverage that includes dental benefits. This gap will likely have a greater impact on families of lower incomes and people of color.

"This new analysis illustrates the concerning impact that the Medicaid redetermination process will have on oral health equity for millions of people across our nation, especially in some of the most marginalized populations," said CareQuest Institute for Oral Health CEO and President Myechia Minter-Jordan, MD, MBA. "We cannot walk back the incredible progress made to strengthen Medicaid dental coverage and connect more people with care in recent years. Access to oral health is critical to good overall health and well-being."

Poor oral health has a direct link to a person's overall health ? including greater risk of diabetes, high blood pressure, obesity, dementia, mental health, and adverse birth outcomes. We also know that regular preventive dental care significantly saves overall medical and dental care costs. For example, one recent study found that diabetics who were treated for periodontal disease saw their overall health care costs decrease by 12 to 14 percent. In addition, as states grapple with the high costs of emergency room visits, access to preventive dental care has been shown to reduce emergency room visits by patients due to oral health problems.

As community and state organizations support impacted Medicaid enrollees navigate this redetermination process, we must elevate the importance of oral health and help people find new coverage options that include dental benefits.

About CareQuest Institute for Oral Health®

CareQuest Institute for Oral Health® is a national nonprofit championing a more equitable future where every person can reach their full potential through excellent health. We do this through our work in grantmaking, research, health improvement programs, policy and advocacy, and education as well as our leadership in dental benefits and innovation advancements. We collaborate with thought leaders, health care providers, patients, and local, state, and federal stakeholders, to accelerate oral health care transformation and create a system designed for everyone. To learn more, visit carequest.org and follow us on Twitter, LinkedIn, Facebook, and Instagram.


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: